Key Financial Data Of Group

ROHTO PHARMACEUTICAL CO.,LTD. - Filing #7249269

Concept As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of group
Business results of group
Net sales
308,625,000,000 JPY
136,557,000,000 JPY
128,937,000,000 JPY
270,840,000,000 JPY
115,355,000,000 JPY
238,664,000,000 JPY
101,207,000,000 JPY
199,646,000,000 JPY
101,009,000,000 JPY
181,287,000,000 JPY
Ordinary profit (loss)
40,430,000,000 JPY
22,679,000,000 JPY
26,696,000,000 JPY
42,434,000,000 JPY
22,462,000,000 JPY
35,568,000,000 JPY
17,516,000,000 JPY
28,750,000,000 JPY
12,564,000,000 JPY
23,910,000,000 JPY
Profit (loss) attributable to owners of parent
31,006,000,000 JPY
30,936,000,000 JPY
26,377,000,000 JPY
21,127,000,000 JPY
16,743,000,000 JPY
Comprehensive income
35,012,000,000 JPY
43,647,000,000 JPY
36,544,000,000 JPY
26,810,000,000 JPY
19,794,000,000 JPY
Net assets
271,440,000,000 JPY
159,288,000,000 JPY
247,036,000,000 JPY
154,272,000,000 JPY
136,582,000,000 JPY
215,078,000,000 JPY
183,994,000,000 JPY
122,859,000,000 JPY
156,612,000,000 JPY
114,864,000,000 JPY
Total assets
421,875,000,000 JPY
232,738,000,000 JPY
346,175,000,000 JPY
208,563,000,000 JPY
191,886,000,000 JPY
309,677,000,000 JPY
274,876,000,000 JPY
172,621,000,000 JPY
226,149,000,000 JPY
153,277,000,000 JPY
Net assets per share
1,149.35
703.23
1,078.04
674.54
597.00
916.93
780.30
536.85
681.71
501.80
Basic earnings (loss) per share
136.11
82.79
87.54
135.61
72.62
115.62
57.14
92.61
39.10
73.39
Diluted earnings per share
135.44
82.38
87.28
135.21
72.42
115.29
56.97
92.34
38.99
73.18
Equity-to-asset ratio
0.616 xbrli:pure
0.683 xbrli:pure
0.710 xbrli:pure
0.738 xbrli:pure
0.710 xbrli:pure
0.676 xbrli:pure
0.648 xbrli:pure
0.710 xbrli:pure
0.688 xbrli:pure
0.747 xbrli:pure
Rate of return on equity
0.123 xbrli:pure
0.121 xbrli:pure
0.138 xbrli:pure
0.136 xbrli:pure
0.128 xbrli:pure
0.136 xbrli:pure
0.110 xbrli:pure
0.127 xbrli:pure
0.081 xbrli:pure
0.117 xbrli:pure
Price-earnings ratio
16.4 xbrli:pure
27.0 xbrli:pure
33.9 xbrli:pure
21.9 xbrli:pure
38.1 xbrli:pure
24.0 xbrli:pure
32.3 xbrli:pure
19.9 xbrli:pure
37.8 xbrli:pure
20.1 xbrli:pure
Net cash provided by (used in) operating activities
36,917,000,000 JPY
34,245,000,000 JPY
30,924,000,000 JPY
27,250,000,000 JPY
20,008,000,000 JPY
Net cash provided by (used in) investing activities
-89,170,000,000 JPY
-16,317,000,000 JPY
-13,176,000,000 JPY
-16,406,000,000 JPY
-10,237,000,000 JPY
Net cash provided by (used in) financing activities
35,319,000,000 JPY
-13,784,000,000 JPY
-16,199,000,000 JPY
3,470,000,000 JPY
-2,347,000,000 JPY
Cash and cash equivalents
73,221,000,000 JPY
86,562,000,000 JPY
77,691,000,000 JPY
70,905,000,000 JPY
52,254,000,000 JPY
Number of employees
5,119 xbrli:pure
2,922 xbrli:pure
530 xbrli:pure
9,083 xbrli:pure
9,144 xbrli:pure
512 xbrli:pure
61 xbrli:pure
1,753 xbrli:pure
7,259 xbrli:pure
1,687 xbrli:pure
1,628 xbrli:pure
7,176 xbrli:pure
6,866 xbrli:pure
1,599 xbrli:pure
6,596 xbrli:pure
1,595 xbrli:pure
Average number of temporary employees
1,193 xbrli:pure
419 xbrli:pure
0 xbrli:pure
1,750 xbrli:pure
1,754 xbrli:pure
138 xbrli:pure
4 xbrli:pure
224 xbrli:pure
1,633 xbrli:pure
224 xbrli:pure
197 xbrli:pure
1,571 xbrli:pure
1,591 xbrli:pure
195 xbrli:pure
1,477 xbrli:pure
193 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.